Because much of the available human literature relates to dermatological and cosmetic formulations rather than injectable peptide research, safety findings should be interpreted within the context of the specific formulation investigated
Ensure sterile preparation, start with small test areas, and avoid application to actively infected or weeping lesions
The ability of fecal microbiota transplantation to reduce inflammation, enhance intestinal barrier integrity through the production of SCFA, and rebalance immune function highlights its potential as an emerging treatment modality, particularly for ME/CFS [162]
Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al